Neurogenesis
Jerusalem, IL · 1 known investors
Find your way into Neurogenesis
NeuroGenesis develops cell therapies for neurodegenerative diseases, leveraging its NG CELL platform to enhance stem cells for treating conditions like multiple sclerosis and ALS. The company is advancing Phase IIb clinical trials in Europe and Israel with a focus on remyelinating and regenerative cellular medicine.
Founders & leadership
DO
Dr. Ofir Karussis
DN
Dr. NetzerVP CMC and Operations
TP
Tal PayneCEO
DH
Dorit HaratiRegulatory & Quality Assurance
DK
Dr. KassisSenior Scientist
Board
MF
Mark FreedmanNeurologist / Neuroimmunology Scientist
DK
Dr. KarussisDirector, MS Center and Neuroimmunology
Investors · 1
Frequently asked questions
- What does Neurogenesis do?
- NeuroGenesis develops cell therapies for neurodegenerative diseases, leveraging its NG CELL platform to enhance stem cells for treating conditions like multiple sclerosis and ALS. The company is advancing Phase IIb clinical trials in Europe and Israel with a focus on remyelinating and regenerative cellular medicine.
- Who founded Neurogenesis?
- Neurogenesis was founded by Dr. Ofir Karussis.
- Who are Neurogenesis's investors?
- Neurogenesis's investors include Rhodium.
- Where is Neurogenesis headquartered?
- Neurogenesis is headquartered in Jerusalem, IL.